CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 159 filers reported holding CASTLE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $639,242 | +24.9% | 37,848 | +1.4% | 0.00% | 0.0% |
Q2 2023 | $511,879 | +57221.3% | 37,309 | -5.1% | 0.00% | 0.0% |
Q1 2023 | $893 | +0.1% | 39,295 | +3.6% | 0.00% | 0.0% |
Q4 2022 | $892 | -99.9% | 37,912 | +1.0% | 0.00% | 0.0% |
Q3 2022 | $978,000 | +30.1% | 37,519 | +9.4% | 0.00% | 0.0% |
Q2 2022 | $752,000 | -23.6% | 34,280 | +56.3% | 0.00% | 0.0% |
Q1 2022 | $984,000 | +9.8% | 21,936 | +5.0% | 0.00% | 0.0% |
Q4 2021 | $896,000 | -36.6% | 20,898 | -1.7% | 0.00% | -50.0% |
Q3 2021 | $1,413,000 | -5.7% | 21,255 | +4.1% | 0.00% | 0.0% |
Q2 2021 | $1,498,000 | +50.9% | 20,423 | +40.8% | 0.00% | +100.0% |
Q1 2021 | $993,000 | +9.5% | 14,510 | +7.5% | 0.00% | 0.0% |
Q4 2020 | $907,000 | +41.3% | 13,503 | +8.2% | 0.00% | 0.0% |
Q3 2020 | $642,000 | +33.5% | 12,476 | -2.3% | 0.00% | 0.0% |
Q2 2020 | $481,000 | +74.3% | 12,764 | +38.1% | 0.00% | 0.0% |
Q1 2020 | $276,000 | – | 9,244 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |